Clover Health Investments (CLOV) Change in Accured Expenses (2020 - 2026)

Clover Health Investments (CLOV) has 7 years of Change in Accured Expenses data on file, last reported at $15.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 478.76% year-over-year to $15.2 million; the trailing twelve-month figure through Mar 2026 stood at $16.2 million (up 220.91% YoY), and the FY2025 full-year result was -$3.1 million, down 54.85% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $15.2 million, up from -$1.4 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $15.2 million in Q1 2026 and bottomed at -$19.3 million in Q2 2023.
• The 5-year median for Change in Accured Expenses is -$678000.0 (2022), against an average of $876647.1.
• Peak annual rise in Change in Accured Expenses reached 2313.42% in 2023, while the deepest fall reached 8610.13% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at -$2.0 million in 2022, then tumbled by 191.83% to -$5.8 million in 2023, then slumped by 184.42% to -$16.4 million in 2024, then soared by 91.28% to -$1.4 million in 2025, then surged by 1165.36% to $15.2 million in 2026.
• The last three Change in Accured Expenses figures came in at $15.2 million (Q1 2026), -$1.4 million (Q4 2025), and -$7.7 million (Q3 2025), per Business Quant data.

Peer Comparison